Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Glenmark Pharmaceuticals Limited
FDA Inspection
•Glenmark Pharmaceuticals Limited•November 11, 2017

Glenmark Pharmaceuticals Limited – FDA Inspection, Nov 11, 2017

Record Details

This FDA Inspection record concerns Glenmark Pharmaceuticals Limited, with an inspection on November 11, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Glenmark Pharmaceuticals Limited
Inspection Date
November 11, 2017
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Dipesh K. Shah
  • Jogy George
View Company Profile

ID · 9dbf23a8-439d-4a57-bd29-3319b9215d79

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1031652
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

7
  1. 21 CFR 211.68(b)Computer control of master formula records
  2. 21 CFR 211.198(b)(2)Complaint Investigation/Follow-Up Findings
  3. 21 CFR 211.25(a)Training--operations, GMPs, written procedures
  4. 21 CFR 211.180(e)Records reviewed annually
  5. 21 CFR 211.100(a)Absence of Written Procedures
  6. 21 CFR 211.192Investigations of discrepancies, failures
  7. 21 CFR 211.22(d)Procedures not in writing, fully followed

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Glenmark Pharmaceuticals Limited

7
DateClassificationOfficeProject area
June 22, 2022OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
April 20, 2019Not classifiedOffice of Inspections and InvestigationsDrug Quality Assurance
September 21, 2018NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
April 19, 2017Not classifiedOffice of Inspections and Investigations
May 29, 2015VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 7 other inspections on the company page
Other documents for Glenmark Pharmaceuticals Limited
  • FDA Inspection 1172425 - 2022-06-22
  • FDA Inspection 1087639 - 2019-04-20
  • FDA Inspection 1070594 - 2018-09-21
  • FDA Inspection 1012923 - 2017-04-19
  • FDA Inspection 929619 - 2015-05-29

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Glenmark Pharmaceuticals Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.